Evidence map›Paper›PMID 33634204›Full record

ArticleOpen forum infectious diseases2021

How the Field of Infectious Diseases Can Leverage Digital Strategy and Social Media Use During a Pandemic.

Jasmine R Marcelin, Nicolás Cortés-Penfield, Carlos Del Rio, Angel Desai, Ignacio Echenique, Bruno Granwehr, Folake Lawal, Kevin Kuriakose, Dong Heun Lee, Maricar Malinis and 4 more

Open access · goldAbstract read
In one paragraph

Article in Open forum infectious diseases, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
7.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Social Media: Flattening Hierarchies for Women and Black, Indigenous, People Of Color (BIPOC) to Enter the Room Where It Happens.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2022
    Article
  11. Digital Strategy and Social Media for Infectious Diseases.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2022
    Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 12 institutions in 1 country.

Jasmine R MarcelinDivision of Infectious Diseases, Department of Medicine, University of Nebraska Medical Center, Omaha, Nebraska, USA.
Nicolás Cortés-PenfieldDivision of Infectious Diseases, Department of Medicine, University of Nebraska Medical Center, Omaha, Nebraska, USA.
Carlos Del RioDivision of Infectious Diseases, Department of Medicine, Emory University, Atlanta, Georgia, USA.
Angel DesaiDivision of Infectious Diseases, Department of Medicine, University of California-Davis Medical Center, Sacramento, California, USA.
Ignacio EcheniqueTeva Pharmaceuticals, Miramar, Florida, USA.
Bruno GranwehrDivision of Infectious Diseases, Department of Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Folake LawalDivision of Infectious Diseases, Department of Medicine, Medical College of Georgia at Augusta University, Georgia USA.
Kevin KuriakoseSection of Infectious Diseases, Renown Health, Reno, Nevada, USA.
Dong Heun LeeDivision of Infectious Diseases, Department of Medicine, University of California San Francisco, San Francisco, California, USA.
Maricar MalinisSection of Infectious Diseases, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut, USA.ORCID https://orcid.org/0000-0002-5720-9994
Diandra RuideraTri-City Medical Center, Oceanside, California, USA.
Javeed SiddiquiTeleMed2U, Roseville, California, USA.
Andrej SpecDivision of Infectious Diseases, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri, USA.ORCID https://orcid.org/0000-0001-7612-4710
Talia H SwartzDivision of Infectious Diseases, Department of Medicine, Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA.ORCID https://orcid.org/0000-0003-1572-045X
University of Nebraska Medical Center · USAugusta University · USEmory University · USIcahn School of Medicine at Mount Sinai · USRenown Health · USTeva Pharmaceuticals (United States) · USThe University of Texas MD Anderson Cancer Center · USTri-City Medical Center · USUniversity of California Davis Medical Center · USUniversity of California, San Francisco · USWashington University in St. Louis · USYale University · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
NCATS NIH HHS UL1 TR001863
6 · The paper itself

Abstract

Rapid information dissemination is critical in a world changing rapidly due to global threats. Ubiquitous internet access has created new methods of information dissemination that are rapid, far-reaching, and universally accessible. However, inaccuracies may accompany rapid information dissemination, and rigorous evaluation of primary data through various forms of peer review is crucial. In an era in which high-quality information can save lives, it is critical that infectious diseases specialists are well versed in digital strategy to effectively disseminate information to colleagues and the community and diminish voices spreading misinformation. In this study, we review how social media can be used for rapid dissemination of quality information, benefits and pitfalls of social media use, and general recommendations for developing a digital strategy as an infectious diseases specialist. We will describe how the Infectious Diseases Society of America has leveraged digital strategy and social media and how individuals can amplify these resources to disseminate information, provide clinical knowledge, community guidance, and build their own person brand. We conclude in providing guidance to infectious diseases specialists in aiming to build and preserve public trust, consider their audience and specific goals, and use social media to highlight the value of the field of infectious diseases.

Indexed as

digital strategyinfectious diseasesinformation disseminationsocial media

Identifiers

PMID33634204
PMCPMC7896640
OpenAlexW3122848512

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.